KR20230028614A - Hangover Relief and Functional Food Composition Containing Propolis - Google Patents
Hangover Relief and Functional Food Composition Containing Propolis Download PDFInfo
- Publication number
- KR20230028614A KR20230028614A KR1020210109228A KR20210109228A KR20230028614A KR 20230028614 A KR20230028614 A KR 20230028614A KR 1020210109228 A KR1020210109228 A KR 1020210109228A KR 20210109228 A KR20210109228 A KR 20210109228A KR 20230028614 A KR20230028614 A KR 20230028614A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- vitamin
- propolis
- extract
- functional food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 241000241413 Propolis Species 0.000 title claims abstract description 45
- 229940069949 propolis Drugs 0.000 title claims abstract description 45
- 206010019133 Hangover Diseases 0.000 title claims abstract description 36
- 239000000203 mixture Substances 0.000 title claims abstract description 27
- 235000013376 functional food Nutrition 0.000 title claims abstract description 24
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 40
- 239000000843 powder Substances 0.000 claims abstract description 40
- 239000012141 concentrate Substances 0.000 claims abstract description 33
- 239000000284 extract Substances 0.000 claims abstract description 24
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 20
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 20
- 239000011718 vitamin C Substances 0.000 claims abstract description 20
- 229940041514 candida albicans extract Drugs 0.000 claims abstract description 17
- 229940096421 milk thistle extract Drugs 0.000 claims abstract description 17
- 235000020727 milk thistle extract Nutrition 0.000 claims abstract description 17
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims abstract description 17
- 239000012138 yeast extract Substances 0.000 claims abstract description 17
- 150000001875 compounds Chemical class 0.000 claims abstract description 16
- 240000001439 Opuntia Species 0.000 claims abstract description 8
- 235000013389 Opuntia humifusa var. humifusa Nutrition 0.000 claims abstract description 8
- 235000013361 beverage Nutrition 0.000 claims abstract description 7
- 235000008504 concentrate Nutrition 0.000 claims abstract description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 10
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 10
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 10
- 244000010000 Hovenia dulcis Species 0.000 claims description 8
- 235000008584 Hovenia dulcis Nutrition 0.000 claims description 8
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 8
- 235000012907 honey Nutrition 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 244000241838 Lycium barbarum Species 0.000 claims description 6
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 6
- 241000581835 Monodora junodii Species 0.000 claims description 6
- 235000001014 amino acid Nutrition 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 6
- 239000000796 flavoring agent Substances 0.000 claims description 6
- 235000019634 flavors Nutrition 0.000 claims description 6
- 241001107116 Castanospermum australe Species 0.000 claims description 5
- 241000207199 Citrus Species 0.000 claims description 5
- 229920002261 Corn starch Polymers 0.000 claims description 5
- 229920000858 Cyclodextrin Polymers 0.000 claims description 5
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 5
- 244000068988 Glycine max Species 0.000 claims description 5
- 235000010469 Glycine max Nutrition 0.000 claims description 5
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 5
- 229930064664 L-arginine Natural products 0.000 claims description 5
- 235000014852 L-arginine Nutrition 0.000 claims description 5
- 235000014443 Pyrus communis Nutrition 0.000 claims description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- 229930003471 Vitamin B2 Natural products 0.000 claims description 5
- 235000021279 black bean Nutrition 0.000 claims description 5
- 239000001913 cellulose Substances 0.000 claims description 5
- 229920002678 cellulose Polymers 0.000 claims description 5
- 235000020971 citrus fruits Nutrition 0.000 claims description 5
- 239000008120 corn starch Substances 0.000 claims description 5
- 235000013399 edible fruits Nutrition 0.000 claims description 5
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 5
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 5
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 5
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 5
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 5
- 239000008213 purified water Substances 0.000 claims description 5
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 5
- 229960002477 riboflavin Drugs 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 5
- 239000001509 sodium citrate Substances 0.000 claims description 5
- 229960003080 taurine Drugs 0.000 claims description 5
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 claims description 5
- 229940038773 trisodium citrate Drugs 0.000 claims description 5
- 239000008513 turmeric extract Substances 0.000 claims description 5
- 229940052016 turmeric extract Drugs 0.000 claims description 5
- 235000020240 turmeric extract Nutrition 0.000 claims description 5
- 235000019164 vitamin B2 Nutrition 0.000 claims description 5
- 239000011716 vitamin B2 Substances 0.000 claims description 5
- 239000011812 mixed powder Substances 0.000 claims description 4
- 235000005152 nicotinamide Nutrition 0.000 claims description 4
- 239000011570 nicotinamide Substances 0.000 claims description 4
- 240000007594 Oryza sativa Species 0.000 claims description 3
- 235000007164 Oryza sativa Nutrition 0.000 claims description 3
- 235000009566 rice Nutrition 0.000 claims description 3
- 235000011147 magnesium chloride Nutrition 0.000 claims description 2
- 239000006187 pill Substances 0.000 abstract description 6
- 230000003078 antioxidant effect Effects 0.000 abstract description 4
- 230000008859 change Effects 0.000 abstract description 4
- 230000006870 function Effects 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 49
- 230000000694 effects Effects 0.000 description 19
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 10
- 238000011156 evaluation Methods 0.000 description 10
- 238000012742 biochemical analysis Methods 0.000 description 9
- 238000000354 decomposition reaction Methods 0.000 description 9
- 238000005259 measurement Methods 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 6
- 108010088751 Albumins Proteins 0.000 description 5
- 102000009027 Albumins Human genes 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 229940109239 creatinine Drugs 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000010835 comparative analysis Methods 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 229930003935 flavonoid Natural products 0.000 description 4
- 235000017173 flavonoids Nutrition 0.000 description 4
- 150000002215 flavonoids Chemical class 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 206010008635 Cholestasis Diseases 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 235000008586 Hovenia Nutrition 0.000 description 2
- 241000405398 Hovenia Species 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 230000007870 cholestasis Effects 0.000 description 2
- 231100000359 cholestasis Toxicity 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 1
- 101710142885 Arginine N-succinyltransferase Proteins 0.000 description 1
- 240000000724 Berberis vulgaris Species 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 241000219357 Cactaceae Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VSOAQEOCSA-N L-altropyranose Chemical compound OC[C@@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-VSOAQEOCSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 102100023105 Sialin Human genes 0.000 description 1
- 101710105284 Sialin Proteins 0.000 description 1
- 241000320380 Silybum Species 0.000 description 1
- 235000010841 Silybum marianum Nutrition 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- HPYIIXJJVYSMCV-MGDXKYBTSA-N astressin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]1C(N[C@@H](C)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@@H](CCCCNC(=O)CC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(N)=O)=O)C(C)C)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CNC=N1 HPYIIXJJVYSMCV-MGDXKYBTSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000008369 fruit flavor Substances 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 235000021445 popular drink Nutrition 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/385—Concentrates of non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/334—Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/704—Vitamin B
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/704—Vitamin B
- A23V2250/7044—Vitamin B2
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/708—Vitamin C
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Agronomy & Crop Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
본 발명은 숙취해소 및 기능성 식품 조성물에 관한 것으로, 더욱 상세하게는 프로폴리스를 함유하여 숙취해소, 면역력 증진, 항산화효과 등의 기능을 가지되, 주성분의 중량% 변화와 기타화합물의 성분 변화로 음료 또는 환으로 구성되는 프로폴리스를 함유한 숙취해소 및 기능성 식품 조성물에 관한 것이다.The present invention relates to a hangover relieving and functional food composition, and more particularly, contains propolis and has functions such as relieving hangover, enhancing immunity, and antioxidant effect, but changing the weight % of the main component and the composition of other compounds, Or it relates to a hangover relief and functional food composition containing propolis consisting of a ring.
사회적으로 주류 판매량이 증가함에 따라 숙취해소제 시장은 그동안 꾸준히 매출이 증가하고 있다.As sales of alcohol increase socially, the hangover cure market has been steadily increasing sales.
과일향이 첨가된 저도주의 인기 등으로 여성을 위한 주류 시장이 성장하고 있고, 사회적 혼돈과 경제의 불안전성으로 주류 판매량이 증가하여 여러 제약회사에서 숙취해소제에 대한 시판과 연구개발이 활발히 움직이고 있다.Due to the popularity of low-alcohol with fruit flavor, the liquor market for women is growing, and sales of alcoholic beverages are increasing due to social chaos and economic instability, and many pharmaceutical companies are actively conducting research and development of hangover cures.
트랜드 변화가 매우 빠른 한국의 편의점에는 매일 새로운 상품들이 쏟아지는데, 숙취해소제에 대한 변화는 적은 실정이다.Convenience stores in Korea, where trends change very quickly, are flooded with new products every day, but there is little change in hangover cures.
포장도 다르고, 브랜드도 다르지만, 차별화를 느끼기 힘든 올드한 디자인들과 한약제같은 맛을 가진 제품들이 일반적으로 시중에 유통되고 있다.Although the packaging is different and the brand is different, products with old designs that are difficult to differentiate and taste like herbal medicines are generally distributed on the market.
또한, 기존의 숙취해소제에는 액상과당, 카페인 및 방부제 등 건강에 해로운 물질이 포함되어 있고, 그 효능 또한 불분명한 제품들이 지속적으로 출시되고 있어 소비자들로 하여금 숙취해소제에 대한 불신이 증가하고 있다.In addition, existing hangover relievers contain unhealthy substances such as high-fructose fructose, caffeine, and preservatives, and products with unclear efficacy are continuously being released, increasing consumers' distrust of hangover relievers. .
이에, 효능에 대한 검증이 완료되되, 숙취해소 효과 뿐만 아니라 건강에도 도움이 되고, 맛도 좋아 대중적으로 쉽게 다가갈 수 있는 숙취해소 및 기능성 식품에 대한 소비자들의 요구가 증가하고 있는 실정이다.Accordingly, the verification of efficacy has been completed, but there is an increasing demand from consumers for hangover relieving and functional foods that are not only effective for relieving hangovers but also helpful for health and have good taste and are easily accessible to the public.
(특허문헌 1) KR 10-1210748 B1 (Patent Document 1) KR 10-1210748 B1
(특허문헌 2) KR 10-2021-0022849 A (Patent Document 2) KR 10-2021-0022849 A
본 발명은 상기한 문제점을 개선하기 위하여 발명된 것으로, 주성분으로 프로폴리스추출액, 백년초농축액, 밀크씨슬추출물, 비타민C, 비타민B1염산염 및 효모추출분말이 사용되고, 주성분 중량%와 기타화합물의 성분 변화로 음료 또는 환 형태로 제공될 수 있고, 개선된 대중적인 맛을 통해 소비자가 거부감 없이 섭취하게 되는 프로폴리스를 함유한 숙취해소 및 기능성 식품 조성물을 제공하는데 그 목적이 있다.The present invention was invented to improve the above problems, and propolis extract, prickly pear concentrate, milk thistle extract, vitamin C, vitamin B1 hydrochloride, and yeast extract powder are used as main components, and changes in the weight percent of the main component and other compounds are used. Its purpose is to provide a hangover relief and functional food composition containing propolis, which can be provided in the form of a drink or pill, and which consumers can consume without objection through an improved popular taste.
본 발명의 목적은 이상에서 언급한 목적으로 제한되지 않으며, 언급하지 않은 또 다른 목적들은 아래의 기재로부터 명확하게 이해될 수 있을 것이다. The object of the present invention is not limited to the object mentioned above, and other objects not mentioned will be clearly understood from the description below.
상기 목적을 달성하기 위한 본 발명에 따른 프로폴리스를 함유한 숙취해소 및 기능성 식품 조성물은 프로폴리스추출액, 백년초농축액, 밀크씨슬추출물, 비타민C, 비타민B1염산염 및 효모추출분말의 주성분과 기타화합물로 이루어진 것을 기술적 특징으로 한다.A hangover relief and functional food composition containing propolis according to the present invention for achieving the above object is a main component and other compounds of propolis extract, cactus concentrate, milk thistle extract, vitamin C, vitamin B1 hydrochloride and yeast extract powder. What has been done is a technical feature.
또한, 주성분이 1 내지 2 중량%인 음료형태인 경우, 주성분은 프로폴리스추출액 1 내지 1.3 중량%; 백년초농축액 0.1 내지 0.5 중량%; 밀크씨슬추출물 0.03 내지 0.07 중량%; 비타민C 0.05 내지 0.15 중량%; 비타민B1염산염 0.0001 내지 0.0005 중량%; 및 효모추출분말 0.01 내지 0.05 중량%; 로 이루어진 것을 기술적 특징으로 한다.In addition, in the case of a beverage in which the main component is 1 to 2% by weight, the main component is 1 to 1.3% by weight of a propolis extract; Baeknyeoncho concentrate 0.1 to 0.5% by weight; 0.03 to 0.07% by weight of milk thistle extract; 0.05 to 0.15% by weight of vitamin C; 0.0001 to 0.0005% by weight of vitamin B1 hydrochloride; and 0.01 to 0.05% by weight of yeast extract powder; It is a technical feature that consists of.
또한, 주성분이 28 내지 30 중량%인 환형태인 경우, 주성분은 프로폴리스추출액 0.3 내지 0.5 중량%; 백년초농축액 8 내지 9 중량%; 밀크씨슬추출물 1.3 내지 1.9 중량%; 비타민C 1.5 내지 2.5 중량%; 비타민B1염산염 0.05 내지 0.15 중량%; 및 효모추출분말 16 내지 17 중량%; 로 이루어진 것을 기술적 특징으로 한다.In addition, when the main component is 28 to 30% by weight in the form of a ring, the main component is 0.3 to 0.5% by weight of a propolis extract; 8 to 9% by weight of Baeknyeoncho concentrate; 1.3 to 1.9% by weight of milk thistle extract; 1.5 to 2.5% by weight of vitamin C; 0.05 to 0.15% by weight of vitamin B1 hydrochloride; and 16 to 17% by weight of yeast extract powder; It is a technical feature that consists of.
또한, 상기 숙취해소 및 기능성 식품이 음료 형태인 경우, 상기 기타화합물은 헛개나무과병추출분말, 헛개나무열매농축액, 쌀배아대두발효혼합분말, 구기자농축액, 배농축액, 사양벌꿀, 염화마그네슘, 비타민B6염산염, 타우린, L-아르지닌, 정제소금, 백설탕, 구연산, 구연산삼나트륨, 청사과향, 시클로덱스트린, 정제수로 이루어진 것을 기술적 특징으로 한다.In addition, when the hangover relief and functional food is in the form of a beverage, the other compounds include Hovenia dulcis extract powder, Hovenia dulcis fruit concentrate, rice germ soybean fermented mixed powder, goji berry concentrate, pear concentrate, sage honey, magnesium chloride, and vitamin B6 It is composed of hydrochloride, taurine, L-arginine, refined salt, white sugar, citric acid, trisodium citrate, green apple flavor, cyclodextrin, and purified water.
또한, 상기 숙취해소 및 기능성 식품이 환 형태인 경우, 상기 기타화합물은 검은콩분말, 옥수수전분, 결정셀룰로스, 감귤껍질분말, 히드록시프로필메틸셀룰로스, 울금추출분말, 니코틴산아미드, 아미노산혼합제제, 글리세린, 비타민B2 로 이루어진 것을 기술적 특징으로 한다.In addition, when the hangover relief and functional food is in the form of a ring, the other compounds include black bean powder, corn starch, crystalline cellulose, citrus peel powder, hydroxypropylmethylcellulose, turmeric extract powder, nicotinic acid amide, amino acid mixture, glycerin , It is characterized as being composed of vitamin B2.
상기한 구성에 의한 본 발명은 아래와 같은 효과를 기대할 수 있다.The present invention according to the above configuration can expect the following effects.
기존의 숙취해소제가 가지고 있던 액상과당, 카페인 및 방부제 등을 모두 제외하여 건강한 식품을 제공하는 것이 가능하게 된다.It becomes possible to provide healthy food by excluding all of the liquid fructose, caffeine, and preservatives that existing hangover cures have.
주성분으로 프로폴리스추출액, 백년초농축액, 밀크씨슬추출물, 비타민C, 비타민B1염산염 및 효모추출분말을 사용하여 숙취해소 효과를 제공하는 것이 가능하게 된다.It is possible to provide a hangover relief effect by using propolis extract, prickly pear concentrate, milk thistle extract, vitamin C, vitamin B1 hydrochloride and yeast extract powder as main ingredients.
또한, 프로폴리스의 주요 구성 물질 중 하나인 플라보노이드와 비타민C를 함유하여 항산화 기능, 면연력 증진 및 항균 등을 가진 건강음료로 섭취하는 것이 가능하게 된다.In addition, it contains flavonoids and vitamin C, which are one of the main components of propolis, so that it can be consumed as a health drink with antioxidant function, immunity enhancement, and antibacterial properties.
일반적으로 한약제 맛으로 제작된 숙취해소제의 맛을 대중적인 음료의 맛으로 개선해 소비자가 거부감없이 섭취하는 것이 가능하게 된다.In general, by improving the taste of hangover cures made with the taste of herbal medicines to the taste of popular drinks, it is possible for consumers to consume them without feeling repulsive.
또한, 주성분의 중량% 변화와 기타화합물의 성분 변화로 음료 또는 환 형태로 제작될 수 있어, 소비자로 하여금 섭취 제품에 대한 선택이 가능하게 된다.In addition, it can be produced in the form of a drink or a pill by changing the weight percent of the main component and the composition of other compounds, enabling consumers to select products for consumption.
도 1은 Alcohol 단독투여 대조군과, 본 발명과 Alcohol을 병용투여한 실험군의 Alcohol 측정결과에 대한 비교를 나타낸 그래프이다.
도 2는 Alcohol 단독투여 대조군과, 종래의 기술과 Alcohol을 병용투여한 실험군의 Alcohol 측정결과에 대한 비교를 나타낸 그래프이다.
도 3은 본 발명과 Alcohol을 병용투여한 실험군과, 종래의 기술과 Alcohol을 병용투여한 실험군의 Alcohol 측정결과에 대한 비교를 나타낸 그래프이다.
도 4는 Alcohol 분해효과성 실험에서 정상군의 생화학적 분석 raw 데이터를 나타낸 표이다.
도 5는 Alcohol 분해효과성 실험에서 본 발명과 Alcohol을 병용투여한 실험군의 생화학적 분석 raw 데이터를 나타낸 표이다.
도 6은 Alcohol 분해효과성 실험에서 종래의 기술과 Alcohol을 병용투여한 실험군의 생화학적 분석 raw 데이터를 나타낸 표이다.
도 7은 Alcohol 분해효과성 실험에서 Alcohol을 투여한 대조군의 생화학적 분석 raw 데이터를 나타낸 표이다.1 is a graph showing a comparison of the alcohol measurement results of a control group administered with Alcohol alone and an experimental group administered with the present invention and Alcohol in combination.
Figure 2 is a graph showing the comparison of the Alcohol measurement results of the control group administered with Alcohol alone and the experimental group administered with the prior art and Alcohol in combination.
Figure 3 is a graph showing the comparison of the alcohol measurement results of the experimental group in which the present invention and Alcohol were co-administered and the experimental group in which the prior art and Alcohol were co-administered.
Figure 4 is a table showing the raw data of the biochemical analysis of the normal group in the alcohol degradation effect test.
Figure 5 is a table showing the biochemical analysis raw data of the experimental group in which the present invention and Alcohol were co-administered in the Alcohol decomposition effect test.
Figure 6 is a table showing the raw data of biochemical analysis of the experimental group in which the prior art and Alcohol were co-administered in the Alcohol decomposition effect test.
7 is a table showing the biochemical analysis raw data of the control group administered with Alcohol in the Alcohol decomposition effect test.
이하 본 발명의 바람직한 실시예에 따른 프로폴리스를 함유한 숙취해소 및 기능성 식품 조성물을 도면을 참조하여 상세하게 설명하면 다음과 같다.Hereinafter, a hangover relief and functional food composition containing propolis according to a preferred embodiment of the present invention will be described in detail with reference to the drawings.
도 1은 Alcohol 단독투여 대조군과, 본 발명과 Alcohol을 병용투여한 실험군의 Alcohol 측정결과에 대한 비교를 나타낸 그래프, 도 2는 Alcohol 단독투여 대조군과, 종래의 기술과 Alcohol을 병용투여한 실험군의 Alcohol 측정결과에 대한 비교를 나타낸 그래프, 도 3은 본 발명과 Alcohol을 병용투여한 실험군과, 종래의 기술과 Alcohol을 병용투여한 실험군의 Alcohol 측정결과에 대한 비교를 나타낸 그래프, 도 4는 Alcohol 분해효과성 실험에서 정상군의 생화학적 분석 raw 데이터를 나타낸 표, 도 5는 Alcohol 분해효과성 실험에서 본 발명과 Alcohol을 병용투여한 실험군의 생화학적 분석 raw 데이터를 나타낸 표, 도 6은 Alcohol 분해효과성 실험에서 종래의 기술과 Alcohol을 병용투여한 실험군의 생화학적 분석 raw 데이터를 나타낸 표 및 도 7은 Alcohol 분해효과성 실험에서 Alcohol을 투여한 대조군의 생화학적 분석 raw 데이터를 나타낸 표이다.Figure 1 is a graph showing the comparison of the alcohol measurement results of a control group administered with Alcohol alone and an experimental group administered with the present invention and Alcohol in combination, Figure 2 is a graph showing a comparison of the alcohol measurement results of a control group administered with Alcohol alone and an experimental group administered with conventional technology and Alcohol in combination A graph showing the comparison of measurement results, Figure 3 is a graph showing the comparison of the alcohol measurement results of the experimental group in which the present invention and Alcohol were co-administered, and the experimental group in which the conventional technology and Alcohol were co-administered, Figure 4 is the alcohol decomposition effect A table showing the raw data of biochemical analysis of the normal group in the sex experiment, Figure 5 is a table showing the raw data of biochemical analysis of the experimental group in which the present invention and Alcohol were co-administered in the alcohol degradation effect test, Figure 6 is the alcohol degradation effect A table showing the raw data of the biochemical analysis of the experimental group in which the conventional technique and Alcohol were co-administered in the experiment and FIG. 7 is a table showing the raw data of the biochemical analysis of the control group administered with Alcohol in the Alcohol decomposition effect experiment.
본 발명의 바람직한 실시예에 따른 프로폴리스를 함유한 숙취해소 및 기능성 식품 조성물은 프로폴리스를 핵심으로 개발한 고효능 숙취해소 식품으로 프로폴리스의 주요 구성 물질 중 하나인 플라보노이드와 벌꿀 및 비타민C를 함유할 수 있다.The hangover relief and functional food composition containing propolis according to a preferred embodiment of the present invention is a high-efficiency hangover relief food developed with propolis as the core, and contains flavonoids, honey, and vitamin C, which are one of the main constituents of propolis. can do.
프로폴리스의 플라보노이드 성분은 인체 내의 해로운 활성산소를 억제하는 SOD효소를 활성화하므로 항산화 작용이 뛰어날 수 있고, 비타민C가 파괴되지 않도록 도움을 줄 수 있다.The flavonoid component of propolis activates the SOD enzyme that suppresses harmful active oxygen in the body, so it can have excellent antioxidant action and help prevent vitamin C from being destroyed.
프로폴리스에는 루틴성분이 풍부하게 함유되어 있어 심장에 관련된 질환 및 당뇨에도 효과를 가질 수 있다.Propolis is rich in rutin, so it can have an effect on heart-related diseases and diabetes.
상세하게는, 프로폴리스 추출물에 함유되어 있는 4개의 Di-Ocaffecyl Quinic acid 관련 물질이 함유되어 간 보호효과가 탁월하며, GPT 수준을 낮추고 손상된 간을 보호할 수 있다.In detail, it contains 4 Di-Ocaffecyl Quinic acid-related substances contained in propolis extract, so it has excellent liver protection effect, lowers GPT level and protects damaged liver.
또한, 프로폴리스의 기능성 성분인 플라보노이드는 중심원소에 비타민 P를 함유하고 있으므로 모세혈관을 확장하고 강화시키므로 심혈관질환 및 고혈압 등에 효과를 가질 수 있다.In addition, flavonoids, which are functional components of propolis, contain vitamin P as a central element, so they expand and strengthen capillaries, so they can have effects on cardiovascular disease and high blood pressure.
또한, 프로폴리스는 여러가지 비타민과 무기질, 아미노산 등이 풍부하게 들어 있어 건강 증진에 도움을 주는 것이 가능할 수 있다.In addition, propolis is rich in various vitamins, minerals, amino acids, etc., so it may be possible to help improve health.
상술한 프로폴리스는 지용성 물질로써 침착현상이 생기고 수용화 되기 어려운 성질을 지녔으나, L-아르지닌(생리적인 활성을 나타내는 준필수 아미노산)을 이용하여 침착성을 최소화하고, 수용화가 될 수 있도록 하며, 시음성 및 건강적인 측면에서도 도움을 주는 것이 가능할 수 있다.The above-mentioned propolis is a fat-soluble substance that is prone to deposition and is difficult to dissolve in water. It may be possible to help with taste and health aspects as well.
본 발명의 바람직한 실시예에 따른 프로폴리스를 함유한 숙취해소 및 기능성 식품 조성물은 음료 또는 환 형태로 구성될 수 있으며, 주성분 중량%와 기타화합물의 성분 변화로 형태를 변경하는 것이 가능할 수 있다.The hangover relief and functional food composition containing propolis according to a preferred embodiment of the present invention may be configured in the form of a drink or pill, and the form may be changed by changing the weight percent of the main component and other compounds.
먼저, 음료 형태는 표 1과 같은 성분으로 구성될 수 있다.First, the beverage form may be composed of the ingredients shown in Table 1.
본 발명의 음료 형태는 주성분과 기타화합물로 구성될 수 있다.The beverage form of the present invention may be composed of a main ingredient and other compounds.
주성분은 프로폴리스추출액, 백년초농축액, 밀크씨슬추출물, 비타민C, 비타민B1염산염 및 효모추출분말로 구성될 수 있다.The main components may consist of propolis extract, prickly pear concentrate, milk thistle extract, vitamin C, vitamin B1 hydrochloride and yeast extract powder.
상세하게는, 프로폴리스추출액 1 내지 1.3 중량%, 백년초농축액 0.1 내지 0.5 중량%, 밀크씨슬추출물 0.03 내지 0.07 중량%, 비타민C 0.05 내지 0.15 중량%, 비타민B1염산염 0.0001 내지 0.0005 중량% 및 효모추출분말 0.01 내지 0.05 중량%로 구성될 수 있다.Specifically, 1 to 1.3% by weight of propolis extract, 0.1 to 0.5% by weight of prickly pear concentrate, 0.03 to 0.07% by weight of milk thistle extract, 0.05 to 0.15% by weight of vitamin C, 0.0001 to 0.0005% by weight of vitamin B1 hydrochloride and yeast extract It may consist of 0.01 to 0.05% by weight of the powder.
기타화합물은 헛개나무과병추출분말 0.1 내지 0.5 중량%, 헛개나무열매농축액 1 내지 2 중량%, 쌀배아대두발효혼합분말 0.005 내지 0.015 중량%, 구기자농축액 0.1 내지 0.5 중량%, 배농축액 0.5 내지 1.5 중량%, 사양벌꿀 0.5 내지 1.5 중량%, 염화마그네슘 0.0005 내지 0.0015 중량%, 비타민B6염산염 0.0001 내지 0.0005 중량%, 타우린 0.3 내지 0.7 중량%, L-아르지닌 0.5 내지 1.5 중량%, 정제소금 0.01 내지 0.05 중량%, 백설탕 6 내지 10 중량%, 구연산 0.5 내지 0.9 중량%, 구연산삼나트륨 0.03 내지 0.07 중량%, 청사과향 0.45 내지 0.85 중량%, 시클로덱스트린 0.5 내지 1.5 중량% 및 정제수 80 내지 85 중량%로 구성될 수 있으나, 아래의 표 2와 같이 구성되는 것이 바람직할 수 있다.Other compounds include 0.1 to 0.5% by weight of Hovenia dulcis extract powder, 1 to 2% by weight of Hovenia dulcis fruit concentrate, 0.005 to 0.015% by weight of fermented rice germ soybean powder, 0.1 to 0.5% by weight of goji berry concentrate, and 0.5 to 1.5% by weight of pear concentrate. 0.5 to 1.5% by weight of honey, 0.0005 to 0.0015% by weight of magnesium chloride, 0.0001 to 0.0005% by weight of vitamin B6 hydrochloride, 0.3 to 0.7% by weight of taurine, 0.5 to 1.5% by weight of L-arginine, 0.01 to 0.05% by weight of refined salt %, 6 to 10% by weight of white sugar, 0.5 to 0.9% by weight of citric acid, 0.03 to 0.07% by weight of trisodium citrate, 0.45 to 0.85% by weight of green apple flavor, 0.5 to 1.5% by weight of cyclodextrin, and 80 to 85% by weight of purified water. However, it may be preferable to be configured as shown in Table 2 below.
본 발명의 음료 형태는 3대 천연 항생물질 중 하나인 프로폴리스와 헛개나무, 벌꿀, 구기자농축액 및 밀크씨슬 등의 자연추출물들이 핵심베이스로 구성되어 숙취해소 효과뿐만 아니라 건강음료로도 효용성이 있고, 청사과향 등을 첨가하여 시음감 또한 개선되어 소비자가 거부감없이 맛있게 섭취하는 것이 가능할 수 있다.The beverage form of the present invention is composed of propolis, one of the three natural antibiotics, and natural extracts such as barberry tree, honey, goji berry concentrate, and milk thistle as a core base. The tasting feeling is also improved by adding green apple flavor, etc., so that consumers can enjoy it deliciously without feeling repulsive.
다음으로, 환 형태는 표 3과 같은 성분으로 구성될 수 있다.Next, the ring form may be composed of the components shown in Table 3.
본 발명의 환 형태는 주성분과 기타화합물로 구성될 수 있다.The ring form of the present invention may be composed of the main component and other compounds.
주성분은 프로폴리스추출액, 백년초농축액, 밀크씨슬추출물, 비타민C, 비타민B1염산염 및 효모추출분말로 구성될 수 있다.The main components may consist of propolis extract, prickly pear concentrate, milk thistle extract, vitamin C, vitamin B1 hydrochloride and yeast extract powder.
상세하게는, 프로폴리스추출액 0.3 내지 0.5 중량%, 백년초농축액 8 내지 9 중량%, 밀크씨슬추출물 1.3 내지 1.9 중량%, 비타민C 1.5 내지 2.5 중량%, 비타민B1염산염 0.05 내지 0.15 중량% 및 효모추출분말 16 내지 17 중량%로 구성될 수 있다.Specifically, 0.3 to 0.5% by weight of propolis extract, 8 to 9% by weight of prickly pear concentrate, 1.3 to 1.9% by weight of milk thistle extract, 1.5 to 2.5% by weight of vitamin C, 0.05 to 0.15% by weight of vitamin B1 hydrochloride and yeast extract It may consist of 16 to 17% by weight of the powder.
기타화합물은 검은콩분말 22 내지 26 중량%, 옥수수전분 17 내지 21 중량%, 결정셀룰로스 10 내지 14 중량%, 감귤껍질분말 8 내지 12 중량%, 히드록시프로필메틸셀룰로스 1 내지 3 중량%, 울금추출분말 1 내지 2 중량%, 니코틴산아미드 0.5 내지 1.5 중량%, 아미노산혼합제제 0.1 내지 0.5 중량%, 글리세린 0.1 내지 0.3 중량% 및 비타민B2 0.05 내지 0.15 중량%로 구성될 수 있으나, 아래의 표 4와 같이 구성되는 것이 바람직할 수 있다.Other compounds include 22 to 26% by weight of black bean powder, 17 to 21% by weight of corn starch, 10 to 14% by weight of crystalline cellulose, 8 to 12% by weight of citrus peel powder, 1 to 3% by weight of hydroxypropylmethylcellulose,
이하, 실험결과를 통한 본 발명의 Alcohol 분해효과를 더욱 상세하게 설명하고자 한다.Hereinafter, the alcohol decomposition effect of the present invention through the experimental results will be described in more detail.
6주령 Wistar 수컷 18마리를 3마리당 1cage로 분리 후, 8일동안 순화하였고, 아래의 표 5에 따른 기준에서 검사가 진행되었다.After separating 18 6-week-old Wistar males into 1 cage per 3 animals, they were acclimated for 8 days, and the test was conducted according to the criteria according to Table 5 below.
순화 7일째, 각 군별로 평균 무게를 균등하게 하기 위해 무게 측정을 하고 정상군 6마리, 실험군(본 발명 투여후 Alcohol 투여군) 6마리 및 대조군(Alcohol만 투여) 6마리로 총 3개의 그룹으로 나누었고, 16시간 동안 금식하고 물은 자유롭게 섭취할수 있도록 하였다.On the 7th day of acclimatization, the weight was measured to equalize the average weight of each group, and divided into 3 groups: 6 normal group, 6 experimental group (Alcohol administration group after administration of the present invention), and 6 control group (Alcohol only administration). , fasted for 16 hours and allowed free access to water.
실험군은 본 발명을 10ml/kg 의 용량으로 경구투여 하였고, 투여 후 30분 뒤에 실험군과 대조군의 Rat에 40%의 주정을 10ml/kg 의 용량으로 경구투여 하였다.The experimental group was orally administered with the present invention at a dose of 10ml/kg, and 40% alcohol was orally administered at a dose of 10ml/kg to rats in the experimental and control groups 30 minutes after administration.
Alcohol 투여 5시간 뒤 정상군, 실험군 및 대조군을 마취 후 심장채혈하여 검사를 진행하였다.After 5 hours of alcohol administration, the normal group, the experimental group and the control group were anesthetized and cardiac blood was collected for examination.
추가적으로, 종래의 기술과도 비교를 실험하였고, 모든 생화학적 분석 raw 데이터는 도 4, 도 5, 도 6 및 도 7에서 확인할 수 있다.In addition, comparison with the conventional technique was also experimented, and all biochemical analysis raw data can be found in FIGS. 4, 5, 6 and 7.
<실험결과 1> 정상군과 실험군의 비교평가<
1) 간세포성 누출효소 AST, ALT의 평가1) Evaluation of hepatocellular leaky enzyme AST, ALT
정상군과 실험군 사이에서 AST와 ALT 모두 유의한 차이는 없었다.There was no significant difference in both AST and ALT between the normal and experimental groups.
2) 담즙정체 유발 효소 ALP, GGT의 평가2) Evaluation of cholestasis-inducing enzymes ALP and GGT
정상군과 실험군 사이에서 ALP와 GGT 모두 유의한 차이를 보이지 않았다.There was no significant difference between ALP and GGT between normal and experimental groups.
3) 간 합성능 인자 Protein, Albumin 및 Glucose의 평가3) Assessment of liver synthesis capacity factors Protein, Albumin and Glucose
정상군과 실험군 사이에서 Albumin, Glucose 모두에서 유의한 차이를 보이지 않았다.There was no significant difference in both Albumin and Glucose between the normal group and the experimental group.
그러나, Protein은 정상군(5.23±0.25mg/dL)보다 실험군(4.93±0.26mg/dL)에서 유의하게 낮은 결과를 보여주었다.However, Protein showed significantly lower results in the experimental group (4.93±0.26mg/dL) than in the normal group (5.23±0.25mg/dL).
4) Total cholesterol의 평가4) Evaluation of total cholesterol
Total cholesterol은 정상군과 실험군 사이에서 유의한 차이를 보이지 않았다.Total cholesterol did not show a significant difference between the normal group and the experimental group.
5) 신장기능의 평가 Creatinine, BUN5) Evaluation of kidney function Creatinine, BUN
Creatinine과 BUN은 정상군과 실험군 사이에서 유의한 차이를 보이지 않았다.Creatinine and BUN did not show significant differences between normal and experimental groups.
6) Alcohol 분해 효과성 평가6) Alcohol decomposition effect evaluation
정상군에서는 검출되지 않았으며, 실험군에서는 121.18±22.12mg/dL로 측정되었다.It was not detected in the normal group and was measured at 121.18±22.12mg/dL in the experimental group.
<실험결과 2> 정상군과 대조군의 비교평가<
1) 간세포성 누출효소 AST, ALT의 평가1) Evaluation of hepatocellular leaky enzyme AST, ALT
정상군과 대조군 사이에서 AST와 ALT 모두 유의한 차이는 없었다.There was no significant difference in both AST and ALT between the normal group and the control group.
2) 담즙정체 유발 효소 ALP, GGT의 평가2) Evaluation of cholestasis-inducing enzymes ALP and GGT
정상군과 대조군 사이에서 ALP와 GGT 모두 유의한 차이를 보이지 않았다.There was no significant difference between ALP and GGT between the normal group and the control group.
3) 간 합성능 인자 Protein, Albumin 및 Glucose의 평가3) Assessment of liver synthesis capacity factors Protein, Albumin and Glucose
정상군과 대조군 사이에서 Protein, Albumin은 유의한 차이를 보이지 않았지만, Glucose는 정상군(102.93±9.67mg/dL)보다 대조군(78.22±14.32mg/dL)에서 낮게 측정되었다.There was no significant difference in protein and albumin between the normal group and the control group, but glucose was lower in the control group (78.22 ± 14.32 mg/dL) than in the normal group (102.93 ± 9.67 mg/dL).
4) Total cholesterol의 평가4) Evaluation of total cholesterol
Total cholesterol은 정상군과 대조군 사이에서 유의한 차이를 보이지 않았다.Total cholesterol did not show a significant difference between normal and control groups.
5) 신장기능의 평가 Creatinine, BUN5) Evaluation of kidney function Creatinine, BUN
Creatinine은 정상군과 대조군 사이에서 유의한 차이를 보이지 않았으며, BUN은 정상군(10.35±1.12mg/dL)보다 대조군(14.45±4.00mg/dL)에서 유의하게 높은 결과를 보여주었다.Creatinine showed no significant difference between the normal group and the control group, and BUN showed a significantly higher result in the control group (14.45 ± 4.00 mg/dL) than the normal group (10.35 ± 1.12 mg/dL).
6) Alcohol 분해 효과성 평가6) Alcohol decomposition effect evaluation
정상군에서는 검출되지 않았으며, 대조군에서는 165.97±26.62mg/dL로 측정되어 Alcohol 투여로 인한 혈액 내 상승을 확인할 수 있었다.It was not detected in the normal group, and it was measured as 165.97±26.62mg/dL in the control group, confirming the increase in blood due to Alcohol administration.
<실험결과 3> 실험군과 대조군에서의 생화학적 변화 및 Alcohol 대사량 비교평가<
실험군과 대조군 사이에서 Protein, Albumin, AST, ALT, Creatinine 및 Cholesterol은 유의한 차이를 나타내지 않았다.There were no significant differences in Protein, Albumin, AST, ALT, Creatinine and Cholesterol between the experimental group and the control group.
BUN은 실험군(10.66±3.31mg/dL)이 대조군(14.45±4.00mg/dL)보다 유의하게 낮은 결과를 보여주었다.BUN showed significantly lower results in the experimental group (10.66±3.31mg/dL) than in the control group (14.45±4.00mg/dL).
GGT는 실험군(1.37±0.12U/L)이 대조군(1.45±0.12U/L)보다 유의하게 낮은 결과를 보여주었다.GGT showed significantly lower results in the experimental group (1.37±0.12 U/L) than in the control group (1.45±0.12 U/L).
Glucose는 실험군(118.65±17.00mg/dL)이 대조군(78.72±14.32mg/dL)보다 유의하게 높은 결과를 보여주었다.Glucose showed significantly higher results in the experimental group (118.65±17.00mg/dL) than in the control group (78.72±14.32mg/dL).
Alcohol 측정 결과는 실험군(121.18±22.12mg/dL)이 대조군(165.97±26.62mg/dL)보다 낮게 측정되어 본 발명으로 인한 Alcohol 감소 효과를 확인할 수 있었다.Alcohol measurement results were lower in the experimental group (121.18 ± 22.12mg / dL) than in the control group (165.97 ± 26.62mg / dL), confirming the alcohol reduction effect due to the present invention.
<실험결과 4> 본 발명과 종래의 기술 비교평가<
본 발명+40% Alcohol 병용투여 실험군과 종래의 기술+40% Alcohol 병용투여 실험군 사이에는 알코올 분해 효과 차이가 유의미하게 일어났으며, 본 발명+40% Alcohol 병용투여 실험군이 더 높은 알코올 분해 효과를 보여주었다.There was a significant difference in alcohol decomposition effect between the experimental group of the present invention + 40% Alcohol combined administration and the conventional technique + 40% Alcohol combined administration experimental group, and the present invention + 40% Alcohol combined administration experimental group showed a higher alcohol degradation effect gave.
상기한 실시예는 예시적인 것에 불과한 것으로, 당해 기술분야에 대한 통상의 지식을 가진 자라면 이로부터 다양하게 변형된 다른 실시예가 가능하다.The above embodiment is merely an example, and other embodiments variously modified therefrom are possible to those skilled in the art.
따라서 본 발명의 진정한 기술적 보호범위에는 하기의 청구범위에 기재된 발명의 기술적 사상에 의해 상기의 실시예뿐만 아니라 다양하게 변형된 다른 실시예가 포함되어야 한다.Therefore, the true technical protection scope of the present invention should include not only the above embodiments but also variously modified other embodiments according to the technical spirit of the invention described in the claims below.
Claims (5)
프로폴리스추출액, 백년초농축액, 밀크씨슬추출물, 비타민C, 비타민B1염산염 및 효모추출분말의 주성분과 기타화합물로 이루어진 프로폴리스가 함유된 숙취해소 및 기능성 식품 조성물.In hangover relief and functional foods,
Propolis extract, prickly pear concentrate, milk thistle extract, vitamin C, vitamin B1 hydrochloride and yeast extract powder as main components and other compounds containing propolis to relieve hangover and functional food composition.
주성분이 1 내지 2 중량%인 음료형태인 경우,
주성분은 프로폴리스추출액 1 내지 1.3 중량%;
백년초농축액 0.1 내지 0.5 중량%;
밀크씨슬추출물 0.03 내지 0.07 중량%;
비타민C 0.05 내지 0.15 중량%;
비타민B1염산염 0.0001 내지 0.0005 중량%; 및
효모추출분말 0.01 내지 0.05 중량%; 로 이루어진 것을 특징으로 하는 프로폴리스가 함유된 숙취해소 및 기능성 식품 조성물.The method of claim 1,
In the case of a beverage form in which the main component is 1 to 2% by weight,
The main component is 1 to 1.3% by weight of a propolis extract;
Baeknyeoncho concentrate 0.1 to 0.5% by weight;
0.03 to 0.07% by weight of milk thistle extract;
0.05 to 0.15% by weight of vitamin C;
0.0001 to 0.0005% by weight of vitamin B1 hydrochloride; and
Yeast extract powder 0.01 to 0.05% by weight; Hangover relief and functional food composition containing propolis, characterized in that consisting of.
주성분이 28 내지 30 중량%인 환형태인 경우,
주성분은 프로폴리스추출액 0.3 내지 0.5 중량%;
백년초농축액 8 내지 9 중량%;
밀크씨슬추출물 1.3 내지 1.9 중량%;
비타민C 1.5 내지 2.5 중량%;
비타민B1염산염 0.05 내지 0.15 중량%; 및
효모추출분말 16 내지 17 중량%; 로 이루어진 것을 특징으로 하는 프로폴리스가 함유된 숙취해소 및 기능성 식품 조성물.The method of claim 1,
In the case of a ring form in which the main component is 28 to 30% by weight,
The main component is 0.3 to 0.5% by weight of a propolis extract;
8 to 9% by weight of Baeknyeoncho concentrate;
1.3 to 1.9% by weight of milk thistle extract;
1.5 to 2.5% by weight of vitamin C;
0.05 to 0.15% by weight of vitamin B1 hydrochloride; and
16 to 17% by weight of yeast extract powder; Hangover relief and functional food composition containing propolis, characterized in that consisting of.
상기 기타화합물은 헛개나무과병추출분말, 헛개나무열매농축액, 쌀배아대두발효혼합분말, 구기자농축액, 배농축액, 사양벌꿀, 염화마그네슘, 비타민B6염산염, 타우린, L-아르지닌, 정제소금, 백설탕, 구연산, 구연산삼나트륨, 청사과향, 시클로덱스트린 및 정제수로 이루어진 것을 특징으로 하는 프로폴리스가 함유된 숙취해소 및 기능성 식품 조성물.According to claim 2,
The other compounds are Hovenia dulcis extract powder, Hovenia dulcis fruit concentrate, rice germ soybean fermented mixed powder, goji berry concentrate, pear concentrate, fermented honey, magnesium chloride, vitamin B6 hydrochloride, taurine, L-arginine, refined salt, white sugar, A hangover relief and functional food composition containing propolis, characterized in that it consists of citric acid, trisodium citrate, green apple flavor, cyclodextrin and purified water.
상기 기타화합물은 검은콩분말, 옥수수전분, 결정셀룰로스, 감귤껍질분말, 히드록시프로필메틸셀룰로스, 울금추출분말, 니코틴산아미드, 아미노산혼합제제, 글리세린 및 비타민B2 로 이루어진 것을 특징으로 하는 프로폴리스가 함유된 숙취해소 및 기능성 식품 조성물.
According to claim 3,
The other compounds are black bean powder, corn starch, crystalline cellulose, citrus peel powder, hydroxypropylmethylcellulose, turmeric extract powder, nicotinic acid amide, amino acid mixture, glycerin, and vitamin B2. Hangover relief and functional food composition.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020210109228A KR20230028614A (en) | 2021-08-19 | 2021-08-19 | Hangover Relief and Functional Food Composition Containing Propolis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020210109228A KR20230028614A (en) | 2021-08-19 | 2021-08-19 | Hangover Relief and Functional Food Composition Containing Propolis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20230028614A true KR20230028614A (en) | 2023-03-02 |
Family
ID=85508989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020210109228A Ceased KR20230028614A (en) | 2021-08-19 | 2021-08-19 | Hangover Relief and Functional Food Composition Containing Propolis |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20230028614A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230085543A (en) * | 2021-12-07 | 2023-06-14 | 안창균 | Composition for the prevention of hangover and improving liver functionand Manufacturing method thereof |
| KR20250008652A (en) * | 2023-07-07 | 2025-01-15 | 기성곤 | Hangover recovery drink |
| KR102794709B1 (en) * | 2024-08-30 | 2025-04-15 | 주식회사 이엠케이 | Pill for relieving hangovers and manufacturing method of the same that |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101210748B1 (en) | 2004-04-16 | 2012-12-11 | 동화약품주식회사 | Composition comprising the extract of Acanthopanax sessiliflorus and green tea for treating or alleviating hangover syndrome |
| KR20210022849A (en) | 2019-08-21 | 2021-03-04 | 블랙갈릭코리아 주식회사 | Functional beverage for improving liver function and relieving hangovers comprising extracts from black galic and Hovenia dulcis |
-
2021
- 2021-08-19 KR KR1020210109228A patent/KR20230028614A/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101210748B1 (en) | 2004-04-16 | 2012-12-11 | 동화약품주식회사 | Composition comprising the extract of Acanthopanax sessiliflorus and green tea for treating or alleviating hangover syndrome |
| KR20210022849A (en) | 2019-08-21 | 2021-03-04 | 블랙갈릭코리아 주식회사 | Functional beverage for improving liver function and relieving hangovers comprising extracts from black galic and Hovenia dulcis |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230085543A (en) * | 2021-12-07 | 2023-06-14 | 안창균 | Composition for the prevention of hangover and improving liver functionand Manufacturing method thereof |
| KR20250008652A (en) * | 2023-07-07 | 2025-01-15 | 기성곤 | Hangover recovery drink |
| KR102794709B1 (en) * | 2024-08-30 | 2025-04-15 | 주식회사 이엠케이 | Pill for relieving hangovers and manufacturing method of the same that |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20200352206A1 (en) | Composition and method for mushroom mycelial compound and botanical mixture | |
| KR20230028614A (en) | Hangover Relief and Functional Food Composition Containing Propolis | |
| TWI500391B (en) | Composition for reliving and preventing hangover and beverage comprising composition | |
| US20050276839A1 (en) | Appetite satiation and hydration beverage | |
| CN104544401A (en) | Protein solid drink suitable for diabetic patients | |
| KR101565964B1 (en) | Composition Comprising Water Extracts from Pleurotus eryngii var. ferulea (Pf.). for Treating or Preventing hyperlipidemia | |
| Houston | Treatment of hypertension with nutrition and nutraceutical supplements: Part 2 | |
| US20180296615A1 (en) | Pharmaceutical composition or functional health food for preventing and treating metabolic diseases, containing water extract of pleurotus eryngii var. ferulae (pf.) as active ingredient | |
| KR20160099972A (en) | Composition for preventing, improving or treating burn out syndrome | |
| KR101716297B1 (en) | Method drinks for prevent a metabolic syndrome that made by Hericium erinaceus extracts containing crude drugs extracts. | |
| CN105029553A (en) | Fruit juice-egg-calcium traditional Chinese medicine health beverage and preparation method thereof | |
| Shah et al. | Fruit and fruit products as functional foods | |
| KR102238009B1 (en) | Red ginseng products containing noni and the process for the preparation thereof | |
| KR20170053536A (en) | Beverages for preventing respiratory disease and hyperlipidemia containing Platycodon grandiflorum and its preparing method | |
| KR20190045073A (en) | Dietary herbal composition for improving obesity and method for producing the same | |
| JP2019149978A (en) | Composition having alcohol metabolism promotion effect and food containing the same | |
| KR102577328B1 (en) | Composition for enhancing immunity comprising at least two herbal extracts as an active ingredient | |
| KR101490794B1 (en) | Composition comprising alcohol extracts from oligoporus tephroleucus for treating or preventing hyperlipidemia | |
| KR101490781B1 (en) | Composition comprsing alcohol extracts from albatrellus dispansus for treating or preventing hyperlipidemia | |
| KR102080204B1 (en) | Clathrate compound of Schisandra chinensis extract and method for its production | |
| RU2358562C1 (en) | Vegetable concentrate for "kazan-bionan-3" functional drink | |
| KR102812865B1 (en) | Method for producing fermented chinese matrimony vine powder and fermented chinese matrimony vine powder prepared therefrom | |
| KR102501329B1 (en) | Method for processing plum with improved anti-cancer activity, anti-diabetes activity and effectiveness in improving blood lipid and processed plum using the same | |
| KR102485676B1 (en) | A composition for improving, preventing and treating of obesity comprising Ulva pertusa Kjellman extracts | |
| KR20040063688A (en) | Functional beverage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20210819 |
|
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20210910 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 20210819 Comment text: Patent Application |
|
| PG1501 | Laying open of application | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20240411 Patent event code: PE09021S01D |
|
| PE0601 | Decision on rejection of patent |
Patent event date: 20240624 Comment text: Decision to Refuse Application Patent event code: PE06012S01D |